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Background. Coma is a frequent presentation of severe malaria in adults and an important cause of death. The
role of cerebral swelling in its pathogenesis, and the possible beneﬁt of intravenous mannitol therapy to treat this,
is uncertain.
Methods. A computed tomographic (CT) scan of the cerebrum and lumbar puncture with measurement of
cerebrospinal ﬂuid (CSF) pressure were performed on admission for 126 consecutive adult Indian patients with
cerebral malaria. Patients with brain swelling on CT scan were randomized to adjunctive treatment with intravenous
mannitol (1.5 g/kg followed by 0.5 g/kg every 8 hours; n 5 30) or no adjunctive therapy (n 5 31).
Results. On CT scan 80 (63%) of 126 patients had cerebral swelling, of whom 36 (29%) had moderate or severe
swelling. Extent of brain swelling was not related to coma depth or mortality. CSF pressures were elevated ($200
mm H2O) in 43 (36%) of 120 patients and correlated with CT scan ﬁndings (P for trend 5 .001). Mortality with
mannitol therapy was 9 (30%) of 30 versus 4 (13%) of 31 without adjunctive therapy (hazard ratio, 2.4 [95%
conﬁdence interval, 0.8–7.3]; P 5 .11). Median coma recovery time was 90 hours (range, 22–380 hours) with
mannitol versus 32 hours (range, 5–168 hours) without (P 5 .02).
Conclusions. Brain swelling on CT scan is a common ﬁnding in adult patients with cerebral malaria but is not
related to coma depth or survival. Mannitol therapy as adjunctive treatment for brain swelling in adult cerebral
malaria prolongs coma duration and may be harmful.
Cerebral malaria is the most frequent severe manifes-
tation of falciparum malaria. It presents as unrousable
comaandfever,usuallywithout focal neurologicalsigns;
seizures occur in the majority of children but only in
approximately 12% of adult patients [1–4]. Depth of
coma on presentation has a strong prognostic signiﬁ-
cance for a fatal outcome in both adults and children,
but severe neurological sequelae are uncommon in
survivors [3, 5, 6], although more frequent in children
[4, 7]. The pathophysiology of cerebral malaria is in-
completely understood. Autopsy studies show intense
sequestration of parasitized erythrocytes in the cerebral
microvasculature correlated with coma depth before
death [8], suggesting that the primary pathological
process is microvascular obstruction. Changes in the
blood-brain barrier (BBB) have been described, but
evidence for a generalized increase in BBB permeability
leading to cerebral edema is conﬂicting [9, 10]. Deﬁning
the role of cerebral edema in cerebral malaria has im-
portant consequences for its clinical management, in
particular whether adjunctive treatment with mannitol
could be beneﬁcial. At the time of the study, mannitol
was used in several centers in India as adjunctive treat-
ment in cerebral malaria. This osmotic diuretic lowers
intracranial pressure but might also reduce oxygen free-
radical damage [11]. In a small study, mannitol was
found to reduce intracranial pressure in Kenyan chil-
dren with cerebral malaria but did not prevent a poor
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tality or neurological sequelae in a larger randomized placebo-
controlled trial in Ugandan children with cerebral malaria [13].
A Cochrane analysis concluded that there are insufﬁcient data to
know what the effects of osmotic diuretics are in cerebral ma-
laria [11]. We studied the prevalence of cerebral swelling and
increased intracranial pressure in adult patients with cerebral
malaria.Arandomizedclinicaltrialontheefﬁcacyofintravenous
mannitol was then performed in those patients with cerebral
swelling identiﬁed on computed tomographic (CT) scan.
METHODS
Study Site
The study was conducted at Ispat General Hospital in Rourkela,
Orissa, India. This is a tertiary health care facility with 685 beds,
an 11-bed intensive care unit, and facilities for blood banking.
Patients
Consecutive adult patients (age, $16 years) with coma, deﬁned
as a Glasgow Coma Score (GCS) ,11, and asexual forms of
Plasmodium falciparum in a peripheral blood smear sample
were included into the study provided written informed consent
was obtained from the relatives or accompanying attendant.
Pregnancy, meningitis, or other causes of encephalopathy di-
agnosed by means of lumbar puncture were exclusion criteria.
Ethical approval was obtained from the institutional review
board of Ispat General Hospital. A medical history was taken,
and a full physical examination was conducted and recorded
on a standardized clinical record form. Particular attention
was paid to the neurological examination, which was repeated
after 1 hour in case of convulsions. A full blood count and basic
biochemistry evaluation were performed for all patients. Fatal
cases were reviewed by an independent data safety monitoring
committee (T. K. Bose, MD, and D. Mohanty, MD).
Imaging
A CT scan (Philips, W1000, third-generation) of the brain was
performed within 12 hours of hospitalization for all enrolled
patients. Nonenhanced 8-mm transverse sections were obtained
forthe posteriorfossaand10-mmtransversesectionsforthe rest
of the brain. Additional 5-mm sections were obtained through
the cerebellum and thalamus if focal abnormalities were sus-
pected. Brain swelling was deﬁned as loss of cerebrospinal ﬂuid
(CSF) space, small ventricles, absence of sulci, and/or com-
pression of the perimesencephalic and chiasmatic cisterns. Mild
swelling was deﬁned as a focal or diffuse effacement of sulci or
the Sylvian ﬁssure, without compression of the supratentorial
ventricular system. Moderate swelling was deﬁned as diffuse
obliteration of sulci, Sylvian ﬁssure, and basal cisterns, including
the perimesencephalic and quadrigeminal cisterns, with or
without a minor mass effect in the form of a focal ventricular
distortion. Severe swelling was deﬁned as diffuse obliteration of
sulci, Sylvian ﬁssure, and basal cisterns together with an im-
portant mass effect causing near total obliteration of the su-
pratentorial ventricular system and generalized hypodensity of
brain parenchyma. Scans were read by 2 independent radiol-
ogists blinded to the clinical status of the patient. A total of 11
cases were read by a third radiologist because of incongruent
interpretation, and a ﬁnal decision was made by consensus,
which was settled as moderate edema in 6 patients and mild
edema in 5 patients.
Cerebrospinal Fluid Pressure
Lumbar puncture was performed after interpretation of the
CT scan images for the potential risk of herniation. CSF
pressure was measured with a spinal manometer. A small
volume of 1–2 mL of CSF (the column of ﬂuid inside the
manometer) was obtained for microbiological, cytological,
and biochemical analyses. Raised intracranial pressure was
deﬁned as an opening pressure $200 mmH2Oa n ds e v e r e
intracranial hypertension as $400 mmH2O.
Patient Management
Patients were closely monitored, at least once every 4 hours, for
vital signs, GCS, neurological deﬁcits, pupillary signs, and urine
output. Patients were treated with a loading dose of quinine
dihydrochloride20mg salt/kg bodyweight followedby10mg/kg
body weight every 8 hours in accordance with World Health
Organization guidelines [14]. The study was performed before
2006 when intravenous artesunate became ﬁrst-line antimalarial
treatment. When the patient was able to take foods, antimalarial
therapy was changed to oral quinine sulphate (10 mg/kg every 8
hours) to complete a total course of 7 days. Seizures were treated
withintravenousdiazepam(10mg)and,ifconvulsionspersisted,
with intravenous phenytoin (15 mg/kg). Whole-blood trans-
fusion was administered if hemoglobin concentrations dropped
below 5 g/dL. Patients with malaria-associated acute renal failure
underwent renal replacement therapy (peritoneal dialysis or
hemodialysis). Mechanical ventilator support was given in case
of respiratory insufﬁciency. Hypoglycemia was closely moni-
tored and treated promptly with a single dose of 50 mL dextrose
25%. Rehydration was with 0.9% NaCl or Ringer’s lactate.
Mannitol Therapy
Patients with evidence of cerebral swelling on CT scan but
without renal failure (serum creatinine level, .3m g / d L ) ,s e v e r e
anemia (hemoglobin level, ,5 g/dL), or signs of pulmonary
edema were randomized to receive either mannitol as adjunctive
treatment or no adjunctive therapy. This was an open ran-
domized trial. Randomization in blocks of 20 was computer
generated, and the allocation codes were kept in an opaque
envelope. In the adjunctive treatment group, mannitol in a dose
of 1.5 g/kg body weight was infused over a period of 15 minutes,
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regained consciousness or for a maximum period of 72 hours.
All surviving patients were assessed neurologically at discharge;
there was no follow-up beyond discharge.
Statistical Analysis
Comparisons between groups were made by means of Student
t test for normally distributed continuous variables and Mann–
Whitney test for nonnormally distributed continuous variables,
and the v
2 test was used for comparing proportions. Odds ratios
were derived where applicable. In the randomized controlled
trial, survival analysis with comparison of groups by log-rank
test was used. The statistical package was Stata, version 10.0
(Statacorp). The ‘‘test for trend’’ is included in this package
and was used for determining the change in CSF pressures in
relation to severity of swelling on CT scan. The intervention trial
was set up as a pilot study. A total of 60 patients allowed for
showing a difference in coma recovery time of 24 hours with
a signiﬁcance level of .05 and a power of 80%. The unexpected
increase in coma duration in the mannitol-treated patients
prompted the investigators in consultation with the data safety
monitoring committee to refrain from extending the trial
beyond the pilot phase.
RESULTS
Patients
Between 2001 and 2003, a total of 141 patients with cerebral
malaria were screened for eligibility, of which 126 patients were
enrolled in the study (Figure 1). Clinical and laboratory values
are given in Table 1. A total of 32 patients had renal failure,
of which 6 received peritoneal dialysis and 2 hemodialysis.
Overall, 36 (29%) of 126 patients died. None of the patients had
residual neurological sequelae at the time of discharge.
Computed Tomographic Scans
All patients had a CT scan examination of the head within 12
hours after admission; 80 (63%) of 126 showed evidence of
cerebral swelling, although in 44 patients (35%), this swelling
was classiﬁed as mild. In 34 patients (27%), there was moderate
swelling, and in 2 patients (2%), severe swelling. In 4 patients,
other pathology was identiﬁed: intraparenchymal hemorrhage
in 2 patients with concomitant moderate cerebral edema, 1 of
whom died; and 2 patients with lacunar infarctions without
evidence of edema. Baseline characteristics according to the
presence of cerebral swelling are summarized in Table 1. The
group with cerebral swelling was younger, had a higher opening
pressure on lumbar puncture, and showed a trend to more
frequent convulsions. There was no difference in GCS between
patients with different degrees of cerebral swelling on CT scan
of the brain: median GCS was 6 (range, 3–9) in the absence of
swelling, 7 (range, 3–9) in patients with mild swelling, 6 (range,
3–9) in patients with moderate swelling, and 6 (range, 4–7) in
patients with severe swelling. Fifteen (33%) of 46 patients
without cerebral swelling had renal failure (deﬁned as a serum
creatinine level of .3 mg/dL), compared with 17 (21%) of
80 patients with cerebral swelling on CT scan (P 5 .20). Severe
jaundice (total plasma bilirubin level, .3 mg/dL) was present
in 33 (72%) of 46 patients without swelling and in 53 (68%) of
78 patients with swelling (P 5 .69), whereas severe anemia
(hemoglobin level, ,5g/dL) was present in 5 (11%) of 46 pa-
tientswithoutswellingversus6 (8%)of76patients withswelling
(P 5 .58), and hypoglycemia (plasma glucose level, ,40 mg/dL)
in 4 (9%) of patients without swelling and 2 (3%) of patients
with swelling (P 5 .19). Excluding the 4 patients with intra-
cerebral hemorrhage or infarction identiﬁed on CT scan, mor-
tality was 16 (36%) of 44 patients without cerebral swelling and
19 (24%) of 78 patients with cerebral swelling (P 5 .21). The
2 patients with severe cerebral swelling both died. At discharge,
no neurological sequelae were detected in surviving patients.
CSF Pressure
Lumbar puncture with manometry was performed for 120
of the 126 patients. No lumbar puncture was performed for
2 patients because of death shortly after the CT scan, for 3
patients because of technical difﬁculties in performing the
puncture, and for 1 patient because of withdrawal of consent
to perform the procedure by the attending relative. Median
time between CT scan and lumbar puncture was 2.45 hours
(range, 1.30–4.40 hours). A total of 43 (36%) of 120 patients
had raised intracranial pressure ($200 mmH2O), and 2 (2%) of
120 had severe intracranial hypertension ($400 mmH2O).
Culture of CSF samples did not grow microorganisms. Mean
CSF glucose level was 112 mg/dL (95% conﬁdence interval [CI],
103–121 mg/dL), and geometric mean CSF protein level was
69 mg/dL (95% CI, 58–79 mg/dL). An elevated (.5 3 10
6/L) Figure 1. Trial profile.
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6/L] was present in
12 (10%) of 120 patients. Mean CSF pressure in these patients
was 185 cmH2O (95% CI, 127–244 cmH2O). Mortality was
15 (35%) of 43 in patients with a pressure of $200 mmH2Oa n d
17 (22%) of 77 in patients with lower pressures (P 5 .14). Mean
CSF pressure was 172 mmH2O (95% CI, 157–186 mmH2O)
in surviving patients and 186 mmH2O (95% CI, 155–217
mmH2O) in patients with a fatal course of the disease (P 5 .33).
In fatal cases, median time between the lumbar puncture and
the time of death was 42 hours (range, 6–384 hours). The fre-
quency of seizures in patients with high CSF pressures ($200
mmH2O) was 22 (51%) of 43, compared with 24 (31%) of
77 in patients with pressures ,200 mmH2O( P 5 .03). Severity
of cerebral swelling on CT scan correlated with CSF opening
pressures (Figure 2; P for trend 5 .001). There was no corre-
lation between CSF opening pressures at hospitalization and
coma recovery times (r 5 –0.05; P 5 .63).
Mannitol Therapy
Of the 80 patients with cerebral malaria and cerebral swelling on
CT scan, a total of 61 patients were randomized to receive
mannitol adjunctive therapy (n 5 30) or no adjunctive therapy
(n 5 31; Figure 1). Baseline characteristics are summarized in
Table 2. The treatment groups were comparable, except for
small differences in plasma sodium and potassium levels.
Mortality in patients treated with mannitol was 9 (30%) of
30, compared with 4 (13%) of 31 in patients not treated with
mannitol (Figure 3; log-rank test v
2 5 2.58; hazard ratio, 2.4
[95% CI, 0.8–7.3]; P 5 .11). When data from patients who died
were censored at the moment of death, coma recovery time in
surviving patients was prolonged in those treated with man-
nitol (Figure 4), with a median coma recovery time of 90 hours
(range, 22–380 hours) with mannitol versus 32 hours (range,
5–168 hours) in patients without adjunctive treatment (Figure
4; log-rank test v
2 5 6.37; hazard ratio, 2.2 [95% CI, 1.2–4.0];
P 5 .01).
DISCUSSION
The most important ﬁnding of this study was that mannitol
as adjunctive treatment for patients with cerebral malaria and
cerebral swelling on CT scan did not reduce mortality but did
prolong coma in the surviving patients. There was a trend to-
ward increased mortality in the group treated with mannitol,
but the study was not powered to show a mortality difference
between treatment groups. Mannitol is an osmotic active drug
that can lower intracranial pressure by absorbing extracellular
Table 1. Baseline Values and Disease Outcome According to the
Presence of Cerebral Edema on CT Scan on Admission
Parameter
No cerebral
edema
(n 5 46)
Cerebral
edema
(n 5 80) P
Age, years 37 (33-40) 28 (25–31) .001
Female sex, no. (%) 11 (24) 20 (25) ..99
Fever before
hospitalization,
days
5 (4–5) 4 (4–5) .67
Altered sensorium
before
hospitalization,
median hours
(range)
10 (2–96) 12 (1–96) .88
Systolic blood
pressure, mmHg
116 (110–122) 114 (109–118) .45
Glasgow Coma Scale,
median (range)
6 (3–9) 7 (3–9) .06
Convulsions at
admission, no. (%)
6 (13) 22 (28) .08
Cerebrospinal ﬂuid
pressure, cm H2O
131 (113–148) 186 (167–205) .001
Hemoglobin level,
g/dL
9.4 (8.6–10.2) 9.9 (9.3–10.5) .36
Sodium level, mmol/L 136 (135–138) 136 (134–138) .79
Potassium level,
mmol/L
3.8 (3.5–4.0) 3.8 (3.6–4.1) .60
Glucose level, mg/dL 106 (89–123) 107 (91–122) .96
Creatinine level,
a
mg/dL
1.8 (1.4–2.2) 1.4 (1.2–1.6) .07
Total bilirubin level,
a
mg/dL
4.1 (2.9–5.9) 4.3 (3.3–5.5) .88
Mortality,
b
proportion (%)
16/44 (36) 19/78 (24) .21
NOTE. Values are mean (95% conﬁdence interval [CI]), except where
otherwise indicated.
a Geometric mean (95% CI).
b Excluding 4 patients with intracerebral hemorrhage or infarction.
Figure 2. Relation between severity of cerebral edema on computed
tomographic scan and opening pressures on lumbar puncture in adult
patients with slide-proven cerebral malaria; P value for trend 5 .001.
CI, confidence interval; CSF, cerebrospinal fluid.
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is common and has been advocated by several authors, but
adequatelypoweredrandomizedclinical trialshavethusfar been
lacking [11]. Our results indicate that mannitol cannot be
recommended as an adjunctive treatment in adult patients with
cerebral malaria and may be harmful. It is possible that hyper-
osmolar mannitol therapy further compromises ﬂuid exchange
in the already affected microcirculation. Extensive sequestration
of parasitized erythrocytes, resulting from cytoadherence to the
endothelium of capillaries and postcapillary venules causing
obstruction of microcirculatory ﬂow, is a central and probably
early feature in the pathophysiology of cerebral malaria [15, 16].
Adult patients who die from cerebral malaria have more prom-
inent sequestration in the brain microvasculature, compared
with severe but noncomatose fatal cases [8, 16]. These studies
show that sequestration is unevenly distributed, with patent
capillariesadjacenttoobstructedvessels,aphenomenonrecently
also observed in living patients by means of video microscopy
[8, 17]. This heterogeneity of microvascular obstruction allow-
ing collateral blood supply might explain the complete recovery
in the majority of patients and absence of cerebral infarction,
which was also rare in the current series. The role of cerebral
edema as a cause of neurological impairment is less clear [18].
Most imaging studies, using both CT and magnetic resonance
imaging (MRI) scanning, ﬁnd that cerebral edema is not
a prominent ﬁnding in most adults with cerebral malaria but
is more frequently reported in African children [19–23]. In the
current study, presence of any brain swelling was recognized in
63% of adult patients with cerebral malaria but was moderate or
severe in only 29% of patients. In addition, there was no cor-
relation between depth of coma or mortality and the ﬁndings
on CT scan of the brain. The results are in accordance with
ﬁndings in postmortem studies in adults dying from cerebral
Table 2. Baseline Values According to Treatment Allocation
Parameter
No mannitol
(n 5 31)
Mannitol
(n 5 30) P
Age, years 32 (28–36) 27 (23–31) .08
Female sex, no. (%) 6 (19) 10 (33) .15
Fever before
hospitalization, days
5 (4–6) 4 (4–5) .26
Altered sensorium
before hospitalization,
median hours (range)
14 (2–96) 9 (1–37) .13
Systolic blood pressure,
mmHg
116 (108–125) 108 (99–118) .20
Glasgow Coma Scale,
median (range)
7 (3–9) 6 (3–8) .12
Convulsions at
hospitalization, no. (%)
9 (29) 11 (37) .22
Cerebrospinal ﬂuid
pressure, cmH2O
167 (138–195) 187 (161–214) .29
Hemoglobin level, g/dL 9.6 (8.7–10.5) 10. 0 (9.0–11.1) .42
Sodium level, mmol/L 134 (132–137) 139 (136–142) .01
Potassium level, mmol/L 3.6 (3.4–3.8) 4.1 (3.7–4.5) .01
Glucose level, mg/dL 95 (6) 85 (7) .96
Creatinine level,
a mg/dL 1.2 (1.0–1.4) 1.1 (0.9–1.2) .36
Total bilirubin level,
a mg/dL 4.6 (3.0–7.0) 2.7 (1.9–3.9) .06
NOTE. Values are mean (95% conﬁdence interval [CI]), except where
otherwise indicated.
a Geometric mean (95% CI).
Figure 3. Survival curves for patients treated with (dashed line)o r
without (solid line) mannitol as adjunctive treatment for cerebral malaria
with cerebral edema identified on computed tomographic scan. Log-rank
test v
2: 2.58; P 5 .11.
Figure 4. Kaplan–Meier curves for the proportion of patients still in
coma after start of treatment with (dashed line) or without (solid line)
mannitol as adjunctive therapy for cerebral malaria with cerebral edema
identified on computed tomographic scan. Data from patients who died
were censored at the moment of death. Log-rank test v
2: 6.37; P 5 .01.
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[24]. Patients with cerebral swelling did present more frequently
with seizures, but epileptic activity itself could have contributed
to the brain swelling. Other rare ﬁndings in this series included
intracerebral hemorrhage and lacunar infarctions. Lacunar in-
farctions have been described in cerebral malaria [22] and could
be related to microvascular obstruction, but we could not rule
out the possibility that the infarctions predated the current
disease episodes.
CSF pressures were elevated to .200 mmH2Oi n4 3( 3 6 % )o f
120 patients, whereas 2 (2%) had severely elevated pressures
of .400 mmH2O. CSF pressures correlated strongly with the
severity of brain swelling identiﬁed by CT scan, which can
be useful in settings where access to CT scanning is limited. CSF
pressures did not correlate with coma depth or coma recovery
times. Our ﬁndings are consistent with earlier reports on CSF
opening pressures in adults with cerebral malaria [25]. In chil-
dren, the threshold level for increased intracranial pressure is
lower (100 mmH2O), and 80% of patients with pediatric cere-
bral malaria in Africa present with opening pressures above
this threshold [26]. In the present study, lumbar puncture was
performed after assessment of potential risk for herniation by
CT scan. In this series, there were no complications related to
the lumbar puncture and there was no relationship between the
time of lumbar puncture and time of death in any patient.
Contributors to cerebral swelling in cerebral malaria include
an increased blood volume caused by the sequestered biomass,
cytotoxic edema, and vasogenic edema. Because parasitized er-
ythrocytes cytoadhere to endothelium in the microcirculation
and have reduced ﬂow rates caused by increased rigidity and
stickiness to other erythrocytes, the fraction of parasitized red
blood cells in the cerebralmicrocirculation can increase toabout
50 times the parasitemia in the peripheral blood [16, 27]. Be-
cause overall cerebral blood ﬂow is uncompromised in cerebral
malaria [28], this extra blood volume must be accommodated
within the intracranial space and will increase intracerebral
pressure. Cytotoxic edema caused by swelling of neurons and
glialandothercellsistheresultofhypoxic,toxic,orotherinjury.
This cannot be distinguished from vasogenic edema by CT scan
but can be differentiated by diffusion-weighted MRI scanning;
studies addressing this are underway. Vasogenic cerebral edema
occurs if the BBB is disrupted and is characteristically reversible
(albeit temporarily) by osmotic diuretics. Cytoadherence might
compromise the functional integrity of the BBB, and immu-
nohistochemical postmortem studies have shown disruption of
endothelial intercellular tight junctions[9,29].However,studies
on the functional integrity of the BBB in adults with cerebral
malaria suggest that the barrier function remains grossly intact
and is only modestly changed in children [29, 30]. Albumin
and immunoglobulin G indices in CSF, a measure of BBB in-
tegrity, were reported mostly within the normal range in a study
on Vietnamese adults with cerebral malaria [31]. The present
results support the conclusion that it is unlikely that increased
cerebral capillary permeability causing brain swelling is the
initial cause of coma in cerebral malaria as originally suggested
by Rigdon and Maegraith in the 1940s and repeated frequently
since [32–34].
In conclusion, this study shows that mild to moderate cere-
bral swelling on CT scan and increased opening pressures on
lumbar puncture are common ﬁndings in adult patients with
cerebralmalaria,buttheirpresencedoesnotcorrelatewithcoma
depth or disease outcome. Mannitol as adjunctive therapy in
patients with cerebral malaria and cerebral swelling is associated
with prolonged coma duration and may be harmful.
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